Pamela Tannenbaum
Affiliations: | Merck Neuroscience, New Brunswick, NJ, United States |
Area:
Behavioral NeuroendocrinologyGoogle:
"Pamela Tannenbaum"Mean distance: 17.23 (cluster 7) | S | N | B | C | P |
Parents
Sign in to add mentor| Kim Wallen | grad student | Emory | |
| David Abbott | post-doc | Wisconsin Regional Primate Research Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gotter AL, Forman MS, Harrell CM, et al. (2016) Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man. Scientific Reports. 6: 27147 |
| Kuduk SD, Skudlarek JW, DiMarco CN, et al. (2015) Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties. Bioorganic & Medicinal Chemistry Letters. 25: 2488-92 |
| Roecker AJ, Mercer SP, Bergman JM, et al. (2015) Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements. Bioorganic & Medicinal Chemistry Letters |
| Raheem IT, Breslin MJ, Bruno J, et al. (2015) Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexant. Bioorganic & Medicinal Chemistry Letters. 25: 444-50 |
| Roecker AJ, Reger TS, Mattern MC, et al. (2014) Discovery of MK-3697: a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia. Bioorganic & Medicinal Chemistry Letters. 24: 4884-90 |
| Gotter AL, Garson SL, Stevens J, et al. (2014) Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators. Bmc Neuroscience. 15: 109 |
| Tannenbaum PL, Stevens J, Binns J, et al. (2014) Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs. Frontiers in Behavioral Neuroscience. 8: 182 |
| Kuduk SD, Skudlarek JW, Di Marco CN, et al. (2014) Synthesis and evaluation of carbon-linked analogs of dual orexin receptor antagonist filorexant. Bioorganic & Medicinal Chemistry Letters. 24: 1784-9 |
| Roecker AJ, Mercer SP, Schreier JD, et al. (2014) Discovery of 5''-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2':5',3''-terpyridine-3'-carboxamide (MK-1064): a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia. Chemmedchem. 9: 311-22 |
| Ramirez AD, Gotter AL, Fox SV, et al. (2013) Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators. Frontiers in Neuroscience. 7: 254 |